Antitumor and antimetastatic activity of interleukin-12.
Hendrzak
J A
JA
Department of Oncology, Hoffman-La Roche Inc., Nutley, NJ 07110, USA.
Brunda
M J
MJ
D000818:Animals; D002455:Cell Division; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D018664:Interleukin-12 / Q000737:chemistry / Q000235:genetics / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D051379:Mice; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D018123:Receptors, Interleukin / Q000737:chemistry / Q000502:physiology; D053707:Receptors, Interleukin-12; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000276:immunology
D007155:Immunologic Factors; D018123:Receptors, Interleukin; D053707:Receptors, Interleukin-12; D018664:Interleukin-12